ExtendedTM infusion set

The only infusion set indicated for up to 7 days of wear.

Shop now
Extended infusion set

One set change per week compared to every 2 to 3 days1

The first and only infusion set and reservoir to be designed for longer wear, without compromising comfort1 or insulin delivery.2

5 changes per month versus 10 changes per month with another pump system or infusion set.

Advancing insulin delivery in pump therapy

Use the ExtendedTM infusion set and ExtendedTM reservoir with the MiniMedTM 780G system - the only system with Meal DetectionTM technology† that provides automatic adjustments and corrections to sugar levels every 5 minutes.‡

Learn more

Footnotes
1. Chattaraj S, et al. The Medtronic extended-wear infusion set: Determining mechanisms of action. As presented at the 14th International Conference on Advanced Technologies & Treatments for Diabetes; June 2-5, 2021.
2. Chattaraj S, et al. Study of insulin stability impact on pump therapy: Test model development. Diabetes. 2020;69 (Supplement 1):1012-P
3. Zhang G, et al. Assessment of adhesive patches for an extended-wear infusion set. Diabetes. 2020;69 (Supplement 1):986-P
4. Chattaraj S, et al. 1167-P - CSII and Insulin: Does extending the wear duration of infusion sets save expensive insulin? 80th ADA International Conference, June 2020.
5. Medtronic Data on File. MiniMed™ Mio™ Advance US Pivotal Trials. 152 patients interviewed. 2020.
6. MRM 17430 MiniMed™ Mio Advance claims from Human Factors Testing. Medtronic data on file.
7. IFU & User Guide Comparison. Medtronic data on File.

References
† Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
‡ Refers to SmartGuard™ feature. Individual results may vary.

Important Safety Information: Extended Infusion Set 

The Extended Infusion Set is indicated for up to 7 days of wear for the subcutaneous infusion of insulin from an infusion pump. It is NOT indicated for intravenous (IV) infusion or the infusion of blood or blood products. Inaccurate medication delivery, infection and/or site irritation may result from improper insertion and maintenance of the infusion site. Before insertion, clean the insertion site with isopropyl alcohol. Remove the needle guard before inserting the infusion set. If using this infusion set for the first time, do the first set-up in the presence of your healthcare professional. Do not leave air in the infusion set. Prime completely. Check frequently to make sure the soft cannula remains firmly in place as you may not feel pain if it pulls out. The soft cannula must always be completely inserted to receive the full amount of medication. If the infusion site becomes inflamed, replace the set, and use a new site until the first site has healed. Replace the infusion set if the tape becomes loose, or if the soft cannula becomes fully or partially dislodged from the skin. Regularly replace the infusion set as indicated in the instructions for use, or per the insulin labeling, whichever duration is shorter. 

For more details, see https://www.minimed.com/important-safety-information. 

Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor

The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.

The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.

WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.

WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.

©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.

DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.